Background review for the excipient propylene glycol
In the context of the revision of the guideline on ‘Excipients in the label and package leaflet of medicinal products for human use’ (CPMP/463/00 Rev. 1)
Draft report published in support to the propylene glycol Q&A document.
For information only
WC500177937.pdf
Adobe Acrobat Document
1.0 MB